Exposure: Medtronic earns $1.5 billion a year in China
Medtronic is already the global device leader. The revenue in fiscal year 2015 was 20.261 billion US dollars. The revenue in the first three quarters of fiscal 2016 reached US$21.266 billion, and it is expected to exceed US$27 billion for the whole year. (The fiscal year here is different from our country. For example, the fiscal year 2015 refers to from April 25, 2014 to April 24, 2015. The fiscal year 2016 is analogous.) But how many of Medtronic's more than $20 billion are earned in China? Recently, Cheng Lifei, vice president of Medtronic Greater China, revealed on BioShow that Medtronic’s total revenue in China is about $1.5 billion. The following is the original words of Cheng Lifei: “The situation of Medtronic in China: Our total revenue in China is almost 1.5 billion US dollars. We have two R&D centers in China, a total of more than 300 engineers, two production bases, and we have made a series of joint ventures and acquisitions. Initiative. We have 4,000 employees, mainly technical sales staff, who are responsible for serving our doctors and departments." Although Cheng Lifei did not directly say that this $1.5 billion is a year's data, Medtronic Global President Omar Ishrak revealed in 2013 that 10% of the company's sales revenue comes from emerging markets (China, India, Latin America, etc.) ). Medtronic's latest earnings report for the third quarter of fiscal 2016 (as of January 29, 2016) also showed that revenue in emerging markets accounted for 13%. From this, it can be inferred that $1.5 billion is the annual revenue in China. More than $1.5 billion? Not much, accounting for less than 8% of Medtronic's total global revenue, and the smallest in the four major divisions. (The four major divisions are: Americas; Greater China; Europe, Middle East and Africa; Asia Pacific) And Medtronic has great ambitions in the Chinese market. Li Xilie, the current president of Greater China, said last year that he hopes that Medtronic will become "the largest medical technology company in China" and hopes that the annual turnover of Greater China can become the first place in the group. In terms of current revenue situation, if you want to become "China's largest medical technology company", even if you have already bought Ke Hui, Medtronic has to work harder to compete with the old rival Johnson. And if you want to be the top pick in the group, I am afraid that it is a bit idiotic to say a dream. The data is evidence: Medtronic’s third quarter of fiscal 2016 (as of January 29, 2016) reported a total revenue of $6.934 billion for the quarter. According to the region, the US market revenue was 3.965 billion US dollars, accounting for 57%; the developed countries except the United States had revenues of 2.066 billion US dollars, accounting for 30%; and emerging markets including China, with revenues of 903 million US dollars. Accounted for 13%. Although the growth rate of emerging markets reached 14%, far exceeding the 4% of the US market, the Greater China region is currently only 1.5 billion US dollars in the whole year. The US has 4 billion US dollars in the first quarter. what! (Small editor Sensen suspects that Li Xilie is wrong, or that the reporter made a mistake. But in February 2013, Medtronic Global President Omar Ishrak also said, "Medtronic’s goal is to develop China into The company's largest market.") L-serine, as a basic amino acid of protein, is widely used in medicine, food, cosmetics and other industries. At present, the global market demand for L-serine is 10000t / A. L-serine is a non essential amino acid, which is an important precursor involved in the synthesis of intracellular biological substances such as purine, pyrimidine and phospholipid. L-serine is a raw material for compound amino acid infusion, and can also be used as a raw material for light chemical industry . In addition, L-serine is widely used in advanced cosmetics at home and abroad because of its special wettability and moisture retention L-Cystine Powder,L-Serine Powder,L-Serine Manufacture,L-Cystine Manufacture Xi'an Tian Guangyuan Biotech Co., Ltd. , https://www.tgybiotech.com
D-serine is one of the most important D-type amino acids in mammals, which is about 1 / 3 of the total free serine. It has been found that high concentration of D-serine exists in the higher center of higher animals, including human beings, and it plays an important role in neurotransmitter. It is found that D-serine plays an important role in the corpus cavernosum and lower esophageal sphincter of mice.